ArticleJournal of clinical medicine2021

Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells.

Michele Massimino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.